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The increasing spread of carbapenemase-producing Enterobacteriaceae (CPE) poses a
serious threat to public health. Recent studies suggested animals as a putative source
of such bacteria. We investigated 19,025 Escherichia coli, 1607 Klebsiella spp. and 570
Enterobacter spp. isolated from livestock, companion animal, horse, and pet samples
between 2009 and 2016 in our routine diagnostic laboratory for reduced susceptibility
to carbapenems (CP) by using meropenem-containing media. Actively screened CP
non-susceptible strains as well as 367 archived ESBL/AmpC-β-lactamase-producing
Enterobacteriaceae were then tested for the presence of CP genes by PCRs. Among
21,569 isolates, OXA-48 could be identified as the sole carbapenemase type in 137
(0.64%) strains. The blaOXA-48 gene was located on an ∼60-kb IncL plasmid and
sequence analysis revealed high similarity to reference plasmid pOXA-48a, which has
been involved in the global spread of the blaOXA-48 gene in humans for many years.
Klebsiella pneumoniae was the predominant OXA-48 producer (n = 86; 6.6% of all
K. pneumoniae isolates), followed by E. cloacae (n = 28; 5.0%), Klebsiella oxytoca
(n = 1; 0.3%), and E. coli (n = 22, 0.1%). OXA-48 was not found in livestock, but
in dogs (120/3182; 3.8%), cats (13/792; 1.6%), guinea pig (1/43; 2.3%), rat (1/23;
4.3%), mouse (1/180; 0.6%), and one rabbit (1/144; 0.7%). Genotyping identified few
major clones among the different enterobacteria species, including sequence types
ST11 and ST15 for K. pneumoniae, ST1196 for E. coli, and ST506 and ST78 for
E. cloacae, most of which were previously involved in the dissemination of multidrug-
resistant strains in humans. The majority of OXA-48 isolates (n = 112) originated from
a university veterinary clinic (UVC), while animals from further 16 veterinary institutions
were positive. Clonal analyses suggested nosocomial events related to different species
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and STs in two veterinary clinics and horizontal transfer of the pOXA-48-like plasmid
between bacterial species and animals. A systematic monitoring is urgently needed to
assess the dissemination of CPE not only in livestock but also in companion animals
and veterinary clinics.
Keywords: Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, companion animals, carbapenemase,
nosocomial
INTRODUCTION
According to the World Health Organization, carbapenems
(CP) are intended to be restrictively used for the treatment of
serious human diseases caused by multidrug resistant bacteria
(Anonymous, 2017). Also as a response to the increased
incidence of ESBL- and AmpC-producing Enterobacteriaceae the
worldwide usage of CP has increased by approximately 40% in
recent years (Liu et al., 2016; Loucif et al., 2016b), promoting
the successful spread of carbapenemases in many parts of the
world (Anonymous, 2017). Carbapenemases are a diverse group
of β-lactamases that hydrolyze not only CP but also other
beta-lactam antibiotics. Among the major carbapenemase types
are the K. pneumoniae carbapenemases (KPC), the New Delhi
Metalloprotease (NDM), and the class D β-lactamase OXA-48.
OXA-48 was first detected in Turkey in 2001 before it spread
through the Mediterranean countries to Western Europe (Poirel
et al., 2012b; Van Boeckel et al., 2014). OXA-48-producing
Enterobacteriaceae have been involved in hospital outbreaks in
many parts of the world including Germany (Anonymous, 2016).
The global dissemination of OXA-48 has been mainly attributed
to a conjugative IncL/M plasmid of approximately 60 kb in
size that harbors blaOXA-48 within Tn1999 transposon structures
(Poirel et al., 2012b; Carattoli et al., 2015; Pitout et al., 2015).
In addition, clonal spread of certain OXA-48-producing strains,
such as K. pneumoniae of ST11, ST15, and ST101, has been
described (Voulgari et al., 2013; Branas et al., 2015; Jayol et al.,
2016; Loucif et al., 2016b).
In recent years, the increasing number of reports about
carbapenemases in Enterobacteriaceae in livestock and
companion animals has raised a serious concern about the
role of animals in the spread of CP-resistant bacteria and/or of
plasmids that carry carbapenemase genes (Fischer et al., 2012;
Shaheen et al., 2013; Schmiedel et al., 2014; Braun et al., 2016;
Dolejska et al., 2016; Gonzalez-Torralba et al., 2016; Hamza et al.,
2016; Liu et al., 2016; Loucif et al., 2016a; Yousfi et al., 2016,
2017; Melo et al., 2017; Pulss et al., 2017). In 2013, we described
the emergence of OXA-48, which to that time was already highly
disseminated in human patients, for the first time in isolates from
dogs and cats in Germany (Stolle et al., 2013). Since then, further
sporadic findings of OXA-48-like carbapenemases were reported
from companion and livestock animals in different parts of the
world (Schmiedel et al., 2014; Al Bayssari et al., 2015; Braun et al.,
2016; Hamza et al., 2016; Liu et al., 2016; Yousfi et al., 2016, 2017;
Melo et al., 2017; Pulss et al., 2017).
In the present study, we investigated the emergence
of carbapenemase-producing Enterobacteriaceae (CPE) in
companion animals and livestock. We describe the chronology of
a long-term spread of OXA-48-producing Enterobacteriaceae in
a veterinary teaching hospital for small animals in Germany and
could additionally demonstrate that OXA-48-positive bacteria
and/or OXA-48 plasmids have independently emerged in several
veterinary clinics throughout Germany.
MATERIALS AND METHODS
Bacterial Isolates, Screening for
Carbapenem Resistance, and Detection
of β-Lactamase Genes
From June 2012 to December 2016, 19,025 E. coli, 1607 Klebsiella
spp., and 570 Enterobacter spp. isolates that were obtained
in our veterinary microbiological laboratory from clinical and
fecal samples of different animal species predominantly from
Germany were tested for reduced susceptibility to CP using
1 ml MH broth containing a 10-µg meropenem disk (June
2012–March 2015) or MH agar supplemented with 0.5 µg/ml
meropenem (April 2015–December 2016), respectively. Strains
that showed growth in the screening media were further tested
for the presence of carbapenemase genes blaNDM-like, blaKPC-like,
blaVIM-like, and blaOXA-48-like by PCR (Grobner et al., 2009;
Pfeifer et al., 2011; Stolle et al., 2013). In case a carbapenemase
gene was detected, the strains were additionally tested for ESBL
genes (blaCTX-M-like, blaSHV-like, blaTEM-like, and blaOXA-like) and
AmpC-β-lactamase genes (blaCMY-like, blaDHA-like, blaACC-like,
and blaFOX-like) using specific primers and conditions previously
described (Grimm et al., 2004; Ewers et al., 2010; Chen et al.,
2015; Yousfi et al., 2017). After amplification of beta-lactamase
genes and carbapenemase genes, all positive amplicons were
sequenced by a commercial sequencing company (LGC GmbH,
Berlin, Germany).
Additional 367 archived ESBL/AmpC β-lactamase producing
Enterobacteriaceae isolates, namely 247 E. coli, 70 Klebsiella spp.,
and 50 Enterobacter spp. that had been isolated from clinical
specimens between June 2009 and May 2012 in Germany, were
tested for the presence of the above mentioned carbapenemase
genes by PCR (Grobner et al., 2009; Pfeifer et al., 2011; Stolle et al.,
2013). The overall 21,569 Enterobacteriaceae isolates (19,272
E. coli, 1,307 K. pneumoniae, 365 K. oxytoca, 5 Klebsiella spp.,
438 E. cloacae, 81 E. amnigenus, 49 E. aerogenes, and 52 isolates
belonging to other Enterobacter spp.) were received from pigs
(n = 10,899), cattle (n = 1,889), small ruminants (n = 246), birds
(n = 132), dogs (n = 3,775), cats (n = 932), horses (n = 2,573), pet
animals and rodents (n = 428), zoo and wildlife animals (n = 644),
and from other or unknown animal species (n = 51).
Isolates were obtained from the feces and gastrointestinal tract
(n = 14,155), genital tract (n = 2,211), respiratory tract (n = 1,287),
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organs (n = 1,077), urinary tract (n = 907), skin/hair (n = 433),
wounds (n = 404), ear (n = 163), abdominal cavity/ascites
(n = 113), abscess/fistula (n = 139), milk/udder (n = 83), eye
(n = 53), central venous catheter (n = 52), blood (n = 22), and
from diverse other locations (n = 470).
The majority of fecal samples (75%) were from pigs and
were sent to our diagnostic laboratory for molecular typing of
virulence-associated genes that are predictive for E. coli pathovars
implicated in swine diarrhea and edema disease. In case different
virulence gene profiles were determined, a maximum of three
isolates per sample was delivered to the present study. Porcine
isolates previously published (Pulss et al., 2017) were not included
in this study.
As the study did not follow a specific sampling schedule but
included isolates obtained along with an in-house veterinary
microbiological diagnostic service and also archived strains, the
number of investigated samples per year differed (2009, 43
isolates; 2010, 102 isolates; 2011, 146 isolates; 2012, 1730 isolates;
2013, 3675 isolates; 2014, 3573 isolates; 2015, 6614 isolates; 2016,
5686 isolates).
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing was performed for all isolates
carrying a carbapenemase gene using the VITEK R© 2 system
(AST-card GN38; bioMérieux, Nürtingen, Germany). Minimum
inhibitory concentrations (MICs) were interpreted according to
breakpoints set by the Clinical and Laboratory Standards Institute
(CLSI) for human and veterinary (in case of enrofloxacin,
marbofloxacin, ceftiofur, and gentamicin) Enterobacteriaceae
isolates (Clinical and Laboratory Standards Institute [CLSI],
2013, 2017). Polymyxin B MICs were interpreted according
to manufacturer analogous to Colistin breakpoints given
by the European Committee on Antimicrobial Susceptibility
Testing (EUCAST). Colistin MICs were further evaluated using
microdilution as recommended by the EUCAST and the CLSI1.
Multilocus Sequence Typing (MLST) and
Clonal Analysis by Pulsed-Field Gel
Electrophoresis
MLST was performed using seven housekeeping genes each of
K. pneumoniae and K. oxytoca (gapA, infB, mdh, pgi, phoE, rpoB,
and tonB), E. cloacae (dnaA, fusA, gyrB, leuS, pyrG, rplB, and
rpoB), and E. coli (adk, fumC, gyrB, icd, mdh, purA, and recA).
Details about the MLST schemes, including the primers, PCR
conditions, and methods for allelic and sequence type assignment
are available at MLST databases of the Institute Pasteur for
K. pneumoniae2 and E. coli3 as well as at the PubMLST database
in case of K. oxytoca4 and E. cloacae5.
Macrorestriction analysis and pulsed-field gel electrophoresis
(PFGE) was performed as described previously (Ewers et al.,
2010). Profiles were compared using BioNumerics (Version 6.6,
1http://www.eucast.org/ast_of_bacteria/guidance_documents/
2http://bigsdb.pasteur.fr/klebsiella/klebsiella.html
3http://bigsdb.pasteur.fr/ecoli/ecoli.html
4https://pubmlst.org/koxytoca/
5https://pubmlst.org/ecloacae/
Applied Maths, Belgium) and cluster analysis of Dice similarity
indices were performed based on UPGMA.
Genomic Location of Carbapenemase
Genes
To determine the genomic location of carbapenemase genes,
plasmid DNA, and I-CeuI digested whole-cell DNA were
separated by agarose and PFGE, respectively, and analyzed
by Southern blot hybridization. DNA probes were prepared
using the PCR Dig Probe Synthesis Kit (Boehringer Mannheim
GmbH, Germany) and consisted of a 1,486 bp PCR fragment
specific for 16S rRNA genes (primers SK16R/SK16F), and
an internal PCR fragment specific for the blaOXA-48-like gene
(743 bp; primers OXA-48A/B), respectively (Stolle et al., 2013).
Detection of hybridized DNA molecules was done with the
DIG Luminescent Detection Kit (Boehringer Mannheim GmbH,
Mannheim, Germany).
Transfer of Carbapenemase Genes by
Conjugation
To test whether carbapenemase genes were transferable,
conjugation was performed by the filter mating method at 37◦C
on 48 OXA-48 positive isolates representing different species
and multilocus sequence types (Supplementary Table S1) using
plasmid-free sodium azide resistant E. coli J53 (J53 AziR) as
recipient. Transconjugants were selected on Mueller Hinton agar
plates supplemented with 100 mg/L sodium azide and 0.5 mg/L
meropenem (Sigma-Aldrich, Germany). To confirm transfer of
carbapenemase genes, antimicrobial susceptibility testing and
PCR was performed as described. PCR-based replicon typing
(PBRT) of the main plasmid incompatibility groups reported
in Enterobacteriaceae was performed by using a commercially
available PBRT kit (DIATHEVA, Cartoceto, Italy) (Carattoli
et al., 2005).
Plasmid Profile and Plasmid Sequence
Analysis
Plasmid profiles and estimated sizes were determined using S1
nuclease restriction of genomic DNA and subsequent PFGE
analysis (Stolle et al., 2013). For sequencing of selected OXA-
48 plasmids, the plasmid DNA was harvested from E. coli J53
transconjugants using a QIAfilter Plasmid Midi Kit (Qiagen
GmbH, Hilden, Germany). Plasmid preparation and sequencing
(using illumina MiSeq V2) was done by LGC Genomics GmbH,
Berlin. Sequence data were assembled de novo using SPAdes
Genome Assembler V. 3.86 and sequences were annotated using
the Rapid Annotation using Subsystem Technology (RAST)
server7. PCR mapping was performed to determine the correct
order of plasmid contigs and sequence assemblies using primers
listed in Supplementary Table S1. The presence of known plasmid
contexts within the assemblies that were related to previously
sequenced ones, such as pKPoxa-48N1 (GenBank accession
number NC_021488) and Kp11978-pOXA-48 (NC_019154) was
6http://cab.spbu.ru/software/spades/
7http://rast.nmpdr.org/
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further identified by a BLAST search8 of publicly available
plasmid sequences using Geneious version 7.2.19 (Mairi et al.,
2017). A circular visualization of blaOXA-48 containing plasmids
was performed using BRIG10.
Nucleotide Sequence Accession
Numbers
The nucleotide sequences of OXA-48 plasmid contigs
were deposited at GenBank under the accession numbers
MH213677-MH213682 (pIHIT22059), MH213683-MH213688
(pIHIT22060), MH213689-MH213694 (pIHIT23114),
MH213695-MH213699 (pIHIT25327), MH213700-MH213706
(pIHIT25329), MH213707-MH213711 (pIHIT25661),
MH213712-MH213717 (pIHIT27939), MH213718-MH213722
(pIHIT28629), and MH213721-MH213730 (pIHIT29873).
RESULTS
Distribution of Carbapenemase Genes
We identified 137 (0.64%) isolates that carried a blaOXA-48-like
gene which was determined as blaOXA-48 in all cases. Included
are eight strains (5 K. pneumoniae and 3 E. coli strains)
that have been published previously (Stolle et al., 2013). The
percentage of isolates carrying blaOXA-48 was 14.98% for the
367 archived ESBL/AmpC-β-lactamase producing strains and
0.43% for the isolates obtained by active screening. None of
the 21,569 Enterobacteriaceae isolates harbored any of the other
carbapenemase genes tested.
OXA-48 positive strains were exclusively found in isolates
from non-livestock animals, particularly from dogs (120/3775;
3.2%) and cats (13/932; 1.4%). Single K. pneumoniae strains
were recovered from a guinea pig (1/43; 2.3%), a rat (1/23;
4.3%), a mouse (1/180; 0.6%) and a rabbit (1/144; 0.7%). K.
pneumoniae was the predominant carbapenemase producer in
numbers (n = 86), followed by E. cloacae (n = 28), E. coli
(n = 22), and K. oxytoca (n = 1). Also with respect to the within-
species frequency, K. pneumoniae was the most frequent OXA-48
producer (6.6%), followed by E. cloacae (5.0%), K. oxytoca (0.3%),
and E. coli (0.1%). Referring to dogs and cats, 23.4% (77/329
isolates) and 11.4% (5/44) of the K. pneumoniae isolates were
OXA-48 positive, respectively. The percentage of positive isolates
from dogs and cats was 15.4% (21/136) and 11.3% (7/62) for E.
cloacae and 0.7% (21/3182) and 0.1% (1/792) for E. coli.
Animals carrying OXA-48 positive isolates originated from
different veterinary clinics and/or households in Germany
(Supplementary Document S1). The majority of OXA-48
producers (n = 112; 81.8%) originated from animals that were
hospitalized in a university veterinary clinic (UVC). Additional
five strains were obtained from organ samples received after
necropsy of animals in the Institute of Veterinary Pathology
(IVP) located on the same campus (distance ca. 0.3 km). The
remaining strains were isolated from animals that had been
8https://blast.ncbi.nlm.nih.gov/Blast.cgi
9http://www.geneious.com
10http://brig.sourceforge.net/
admitted to 15 different veterinary practices and clinics (termed
clinic-1 to clinic-15) located in different geographic regions
in Germany (distances between 13 km and 450 km; n = 20
isolates). All non-UVC and non-IVP institutions are referred
to as “external clinics”, the corresponding strains as “external
strains” in the manuscript. Among the 20 external strains were
13 singletons, i.e., isolated from animals in 13 different clinics,
while OXA-48 producers could be repeatedly isolated from two
institutions, namely clinic-3 (5 isolates) and clinic-10 (2 isolates)
(Table 1).
According to the year of isolation, a minimum of two strains
(year 2009) and a maximum of 29 strains (year 2012) were
detected. The relative proportion of OXA-48 positive strains
from dogs and cats according to study year differs from 11.1%
to 37.5% in the retrospective screening period (2009 to May
2012), where preselected ESBL/AmpC-β-lactamase isolates were
investigated, and from 1.0% to 3.7% in the active screening
period, where isolates had not been preselected for a certain
resistance phenotype (Supplementary Figure S1). The four OXA-
48 positive strains from animals other than dogs or cats were
obtained in the year 2010 and were all isolated in the IVP.
Distribution of Other β-Lactamase Genes
Among OXA-48 Positive Isolates
Sixty-one isolates (44.5%) carried the ESBL gene blaCTX-M-15
and one K. pneumoniae isolate was positive for blaCTX-M-27
(Supplementary Figures S2A–C) Fifty-six (65.5%) K. pneumoniae
isolates carried blaCTX-M-15 while this was the case for 18.2%
and 3.6% of the E. coli and E. cloacae isolates, respectively.
The single K. oxytoca isolate was negative for any of the
additionally tested β-lactamase genes. AmpC β-lactamase genes
blaDHA-1 and blaCMY-2 were identified in 20 (14.6%) and
10 (7.3%) of the 137 OXA-48 positive isolates, respectively.
The DHA-1 gene was found in K. pneumoniae (20.9%)
and in E. cloacae isolates (9.1%), while the CMY-2 gene
was almost exclusively determined in E. coli isolates (8/22;
36.4%) and in only two K. pneumoniae isolates (2/86; 2.3%).
Furthermore, 86 (62.8%) of all OXA-48 producing isolates were
positive for blaTEM-1 and 76 (55.5%) isolates for blaOXA-1,
while 104 (75.9%) carried blaSHV-like genes, including blaSHV-1
(2/137; 1.5%), blaSHV-2 (1.5%), blaSHV-11 (13.1%), blaSHV-12
(11.7%), blaSHV-27 (0.7%), and blaSHV-28 (47.4%) as shown in
Supplementary Figures S2A–C. Among the 86 K. pneumoniae
isolates, SHV-28 was the predominant SHV-type (75.6%) while
only few strains harbored SHV-2, SHV-11, and SHV-27.
The SHV-12 enzymes were only detected among E. cloacae
and E. coli isolates (31.1% and 31.8% blaSHV-12 positive,
respectively).
Antimicrobial Susceptibility
Forty-six (33.6%) of the 137 OXA-48 positive Enterobacteriaceae
isolates were resistant to imipenem (≥4 mg/L). The remaining
isolates revealed MICs of either 2 mg/L (49 isolates, 35.8%)
or ≤1 mg/L (42 isolates, 30.7%). E. cloacae was the species
with the highest frequency of imipenem resistance (78.6%
of 28 isolates), followed by K. pneumoniae (29.1%), whereas
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none of the blaOXA-48 positive E. coli isolates was resistant to
imipenem. Sixty-eight (49.6%) isolates had an ESBL phenotype,
which was mainly due to the presence of CTX-M enzymes.
All strains were resistant to ampicillin, piperacillin, and
the amoxicillin–clavulanate combination. The majority of
strains were also resistant to the tested fluoroquinolones
with percentages per species ranging from 90.0 to 100%.
(Table 2). Moreover, different rates of aminoglycoside resistances
were determined, with percentages ranging between 0 for
amikacin, 49.6% for tobramycin, and 52.9% for gentamicin
(Table 2).
Multilocus Sequence Types, Clonal
Relatedness, and Plasmid Profiles of
OXA-48 Producing Bacteria
The 86 OXA-48 positive K. pneumoniae isolates were
predominantly assigned to sequence types ST15 (75.6%)
and ST11 (19.8%) (Figure 1). Other sequence types determined
were ST307 (n = 2), ST661 (n = 1), and ST895 (n = 1), which is
a single locus variant (SLV) of ST11. ST11 and ST15 strains were
mainly observed in the UVC (87.2%) and the epidemiologically
linked IVP (4.7%) and were frequently found between July
2009 and June 2014, before they almost disappeared after that
time period (Figure 2). Major STs among the 28 E. cloacae
strains were ST506 (39.3%), which was found in the UVC
and the IVP but in none of the external clinics, and ST78
(21.4%). Further STs identified were ST114 (n = 2) and its
SLV ST418 (n = 3) as well as ST124 (n = 2), ST265 (n = 1),
and ST507 (n = 3). In contrast to the other species, E. cloacae
strains were highly dispersed with regard to clinic background,
as they were found in animals from 10 external veterinary
clinics.
With the exception of ST1196, which was the predominant
ST (36.4%) among the 22 E. coli strains and appeared in 2012
in the UVC and the IVP (Figure 2), the remaining strains
revealed a high diversity and were distributed among 10 different
STs, including ST648 and ST410, which have previously been
described as emergent ESBL producing clones in various hosts,
including humans (Ewers et al., 2014a; Poirel et al., 2014;
TABLE 1 | Distribution of OXA-producing Enterobacteriaceae isolates according to bacterial species, date and source of isolation.
Veterinary
institutions
Species No. of isolates Date of isolation Isolation source∗ Pure culture Host∗ Epidemiologic
link to UVC
UVC K. pneumoniae 79 08/2009-08/2016 urine (21), wound (20),
CVK (12), abdominal
cavity (6), skin (4),
blood (3), others (13)
yes (24), no (55) dog (75), cat (4)
K. oxytoca 1 11/2012 urine no dog
E. cloacae 14 07/2010-08/2015 CVK (6), urine (2),
tracheal tube (2), others
(4)
E. coli 18 03/2012-10/2016 urine (4), wound (4),
CVK (4), BAL (2), others
(6)
yes (5), no (13) dog (17), cat (1)
External clinics & IVP
IVP K. pneumoniae 4 08/2010-10/2010 liver (2), nose, lung no guinea pig, rat,
rabbit, mouse
no
E. cloacae 1 06/2012 liver no dog yes
Clinic 1 K. pneumoniae 1 10/2010 nose no dog no
Clinic 2 E. coli 1 10/2012 urine yes dog yes
Clinic 3 E. cloacae 4 03/2013-09/2016 axillary swab, skin,
urine, nose
yes (1), no (3) dog (2), cat (2) no
E. coli 1 04/2014 throat no dog no
Clinic 4 E. cloacae 1 01/2013 trachea no dog no
Clinic 5 E. cloacae 1 05/2014 urine unknown dog no
Clinic 6 E. cloacae 1 07/2014 tissue no cat no
Clinic 7 K. pneumoniae 1 11/2014 skin no dog yes
Clinic 8 E. cloacae 1 12/2014 wound no cat no
Clinic 9 E. cloacae 1 12/2014 trachea no dog no
Clinic 10 E. cloacae 2 06/2015, 08/2015 ascites, bulla yes (1), no (1) dog (2) no
Clinic 11 E. cloacae 1 08/2015 wound no dog no
Clinic 12 E. coli 1 12/2016 urine no dog no
Clinic 13 E. cloacae 1 12/2016 bile no cat no
Clinic 14 E. cloacae 1 10/2016 urine unknown dog no
Clinic 15 K. pneumoniae 1 10/2016 urine unknown cat no
∗The number of isolates is given in brackets; UVC, University Clinic; IVP, Institute of Veterinary Pathology; CVK, central venous catheter; BAL, broncho-alveolar lavage.
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Fernandez et al., 2015). Also, our ST648 isolate carried a CTX-
M-15 β-lactamase, while the two ST410 isolates were no ESBL
producers.
PFGE analysis grouped isolates basically according to their
multilocus sequence types (Supplementary Figures S2A–C).
ST15- K. pneumoniae isolates clustered together based on
similarity values of 86.0% to 100% (Kp-pulsotype D). In
case of Kp-ST11 isolates, the similarity values ranged from
92.0% to 100% (Kp-pulsotype C), while isolates of ST307
(Kp-pulsotype A), ST661 (Kp-pulsotype E), and ST895 (Kp-
pulsotype B) clustered separately from each other and in
addition from ST15 and ST11 (< 85% similarity) (Supplementary
Figure S2A). A similar clustering based on assignment to
STs was observed for E. cloacae and E. coli isolates. In
detail, E. coli isolates were grouped into Ec-pulsotypes A-J,
and except for ST617 and ST88 isolates, which clustered
at a similarity value of 85.7%, all other STs belonged
to distinct pulsotypes (Supplementary Figure S2B). The 28
E. cloacae isolates were separated into Ecl-pulsotypes A-F
(Supplementary Figure S2C), which perfectly reflects their ST
assignment.
We identified 11 plasmid profiles among the 22 E. coli, 19
profiles among E. cloacae, and 21 profiles among K. pneumoniae
isolates (Supplementary Figures S2A–C). This indicates an overall
TABLE 2 | Antimicrobial susceptibility of 137 OXA-48-positive Enterobacteriaceae
strains isolated from clinical samples of companion animals.
K. pneumoniae/ K. oxytoca E. cloacae E. coli
Resistance rate [n (%)]
Ampicillin1 87 (100) 28 (100) 22 (100)
Amoxicillin-
clavulanic
acid1
87 (100) 28 (100) 22 (100)
Piperacillin1 87 (100) 28 (100) 22 (100)
Cefalexine1 76 (87.4) 28 (100) 8 (36.4)
Cefpodoxime1 72 (82.8) 20 (71.4) 14 (63.6)
Ceftiofur2 77 (88.5) 27 (96.4) 21 (95.5)
Cefpirome1 56 (64.4) 6 (21.4) 4 (18.2)
Imipenem1 26 (29.9) 22 (78.6) 0
Amikacin1 0 0 0
Gentamicin2 44 (50.6) 14 (50.0) 12 (54.5)
Tobramycin1 46 (52.9) 15 (53.6) 7 (31.8)
Enrofloxacin2 86 (98.9) 27 (96.4) 20 (90.9)
Marbofloxacin2 86 (98.9) 27 (96.4) 20 (90.9)
Tetracycline1 43 (49.4) 21 (75.0) 20 (90.9)
Nitrofurantoin1 26 (29.9) 6 (21.4) 0
Trimethoprim-
sulfamethoxazole1
50 (57.5) 27 (96.4) 18 (81.8)
Chloramphenicol1 22 (25.3) 13 (46.4) 17 (77.3)
Polymyxin B1 0 0 0
1 Interpreted according to CLSI, Performance Standards for Antimicrobial
Susceptibility Testing, 27th ed. CLSI supplement M100, 2017. 2 Interpreted
according to CLSI, Performance Standards for Antimicrobial Disk and Dilution
Susceptibility Tests for Bacteria Isolated from Animals, 3rd ed. CLSI supplement
VET01S, 2015.
high diversity of plasmid content and suggests that strains may
frequently lose and gain plasmids in their different habitats.
However, we also found several isolates that revealed not only
identical STs, but also high relatedness in terms of PFGE
and/or plasmid patterns. This was for example the case for
different subgroups of ST11- and ST15-K. pneumoniae strains
that presented identical plasmid profiles and highly related
macrorestriction profiles although originating from different
time points, clinics, and host species (Supplementary Figure
S2A). The repeated isolation of pulsotype-identical ST15-
K. pneumoniae isolates from dog-86 in the UVC (where the dog
underwent surgery) in October 2014 and in clinic-7 (aftercare-
treatment) and the possibility in November 2014, indicates that
animals may transfer OXA-48 producing Enterobacteriaceae
between different clinics, eventually by contaminating the clinical
environment. Regarding E. coli, one ST1196 strain isolated
from dog-49 in clinic-2 in 2012 revealed >98% similarity in
its pulsotype and an identical plasmid profile as compared to
six strains of the same ST, that were isolated in the UVC
from other dogs and cats a few months earlier (Supplementary
Figure S2C).
For E. cloacae, we found identical plasmid patterns among 7
out of 11 ST506 strains, all obtained from the UVC over a time
period of about 4 years (Supplementary Figure S2B). Likewise,
identical PFGE and plasmid patterns suggested clonality for three
ST507-E. cloacae strains isolated from two cats (cat-6, cat-12)
and one dog (dog-87) in three different clinics (clinic-8, -9, and
-13) in the years 2014 and 2016. Finally, ST78-E. cloacae isolates,
obtained from the UVC (dog-94), clinic-3 (dog-60 and dog-89),
and clinic-6 (cat-5) were highly similar (≥92.1%) based on their
PFGE profiles. Here, however, apart from the regular presence
of the ∼60-kb OXA-48 plasmid, plasmid profiles showed only
partial overlap which may indicate an ongoing exchange of
non-OXA-48 plasmids and/or a different background of the
strains.
Genomic Location of OXA-48 Plasmids
and Conjugation Experiments
S1-nuclease restriction analysis and subsequent hybridization
analysis revealed the presence of an approximately 60 kb-plasmid
and the localization of the blaOXA-48 gene on this plasmid for the
137 OXA-48 positive isolates (data not shown). All 48 isolates
selected for transconjugation assays based on their assignment to
different enterobacterial species, STs, year of isolation, and MIC
values for imipenem, successfully transferred the blaOXA-48 gene
to the recipient E. coli J53. Plasmid profile analysis and replicon
typing revealed the presence of a ∼60-kb IncL plasmid in all
transconjugants (TCs). All TCs exhibited an increase of four-
to fivefold in MICs to ampicillin and piperacillin compared to
the recipient strain. MICs to amoxicillin/clavulanate increased
by two- to fourfold, those to the cephalosporins, cefpodoxim,
ceftiofur, and cefpirom were either the same as in the recipient
strain or showed an increase by two-to fivefold (Supplementary
Table S1). In the majority of the TCs (91.7%), the transfer of
the OXA-48-plasmid resulted in an increased MIC to imipenem
in the recipient strain. In detail, MICs of 2 mg/L, 4 mg/L,
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FIGURE 1 | Multilocus sequence types (STs) of OXA-48 positive Enterobacteriaceae from clinical samples of companion animals with respect to strain origin.
FIGURE 2 | Chronology of appearance of OXA-48-producing Enterobacteriaceae in a University Veterinary Clinic (UVC) and the Institute of Veterinary Pathology (IVP)
located on the same campus as well as in 15 veterinary external clinics outside the campus.
and 8 mg/L were determined in 23, 19, and two of the TCs,
respectively.
Sequence Analysis of OXA-48 Plasmids
We comparatively analyzed selected blaOXA-48 encoding IncL
plasmid sequences from our study with published sequences of
human OXA-48 plasmids that have previously been described
from various bacterial species (Figure 3) (Poirel et al., 2012b;
Berger et al., 2013; Espedido et al., 2013; Chen et al., 2015;
Touati et al., 2017). Like in pKPoxa-48N1, blaOXA-48 was part of
the composite transposon Tn1999.2, that was first described in
the context of the spread of OXA-48-producing K. pneumoniae
isolates in Turkey (Carrer et al., 2008; Berger et al., 2013). In
contrast to Tn1999.1, which was identified in the prototype
plasmid pOXA-48a in K. pneumoniae strain 11978 (Poirel et al.,
2012b), the Tn1999.2 isoform contains an IS1R element inserted
into the IS1999 element located upstream of blaOXA-48. In
addition, we could detect almost the complete sequence and
gene organization of pKPoxa-48N1 in the plasmid contigs of our
isolates with an overall coverage of 98% and sequence identity of
99%. Irrespective of the enterobacterial isolate, host, and clinic
origin, the animal OXA-48 plasmids revealed almost sequence
identity. Figure 3 provides a circular view of OXA-48 plasmids
from nine animal isolates representing different species and
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FIGURE 3 | Sequence comparison of plasmid pKPoxa-48N1 and other published OXA-48 plasmids with plasmid sequence contigs of OXA-48 plasmids from animal
Enterobacteriaceae. Plasmids (GenBank accession number, species, host, country, year of isolation) used for comparison: pKPoxa-48N1 (NC_021488;
K. pneumoniae, human, France, 2010) (Berger et al., 2013); Kp11978-pOXA-48a (NC_019154, K. pneumoniae, human, Turkey, 2001) (Poirel et al., 2012b);
pJEG011-Kp002 (KC354801.1, K. pneumoniae, human, Australia, 2010) (Espedido et al., 2013); pRAY_Kpn-OXA-48 (KX524525, K. pneumoniae, human, Italy,
2013) (Touati et al., 2017), pWI2-OXA-48 (LT838202, E. coli, human) [direct submission to NCBI database], pCF29_OXA-48 (LN864820; Citrobacter freundii,
Lebanon) (direct submission to NCBI database), pOXA-48-Pm (KP025948, Proteus mirabilis, human, Palestine, 2012) (Chen et al., 2015).
STs and obtained from the UVC and from external clinics as
compared with the reference plasmids. Plasmid mapping of the
remaining 39 blaOXA-48 carrying plasmids of transconjugants
by 22 PCRs spanning almost the entire plasmid sequence (see
Supplementary Table S2) revealed that all 48 plasmids showed a
positive result with the expected amplicon sizes, as referred to the
reference plasmid pKPoxa-48N1.
DISCUSSION
Our results suggest that OXA-48 type carbapenemases are
on their way to successfully entering the companion animal
population and/or veterinary clinics in Germany. These findings
add up to a growing number of reports about the emergence of
OXA-48-CPE in cats, dogs, horses, and pet birds in Germany
(Stolle et al., 2013; Schmiedel et al., 2014), Algeria (Yousfi et al.,
2016; Yousfi et al., 2017), France (Melo et al., 2017), and the
United States (Liu et al., 2016). In the present study, guinea pig,
rat, mouse, and rabbit could be identified as an additional source
of CPE, suggesting a broader host spectrum of such bacteria than
previously known.
We observed a frequency of 0.43% OXA-48-producers among
21,202 Enterobacteriaceae that were not preselected for any
antimicrobial resistance. This basically reflects numbers from
previous studies, where 0.26% and 2.3% OXA-producing bacteria
have been determined among 383 non-preselected isolates from
healthy cats and dogs in France (Melo et al., 2017) and 533 rectal
swabs obtained from healthy and diseased pets in different cities
in Algeria (Yousfi et al., 2016), respectively. Not unexpected, the
frequency of OXA-48-producers was considerably higher among
our set of 367 archived ESBL-/AmpC-β-lactamase producing
isolates (14.98%). Similarly, Liu et al. (2016) determined OXA-
48 in 19.1% of 68 ESBL-producing E. coli isolates from diseased
dogs and cats in the United States, supporting the frequent
multidrug-resistant (MDR) phenotype of CPE (Liu et al., 2016).
Indeed, almost 50% of our OXA-48-producing isolates showed
an ESBL phenotype and high rates of resistances to other
antimicrobials, including fluoroquinolones, aminoglycosides,
penicillins, cephalosporins, and tetracycline, probably due to
antibiotic selective pressure. Data regarding previous antibiotic
treatment were only partially available, but at least 13 (9.5%) of
the animals carrying OXA-48-producing bacteria had received
cephalosporins (2nd or 3rd generation), while 27.7%, 40.1%, and
60.6% had been treated with aminopenicillins, fluoroquinolones,
and amoxicillin-clavulanic acid, respectively, either prior to
their admission to a clinic or during their stay. It has been
documented, that not only CP, which are not registered for use
in veterinary medicine, but also other classes of antimicrobials,
including cephalosporins, fluoroquinolones, aminopenicillins, or
penicillin-β-lactamase inhibitor combinations might co-select
for carbapenemase genes and contribute significantly to the
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development of resistance to CP (Poirel et al., 2012a; Jiao et al.,
2015).
Our previous work was the first to suggest a nosocomial
dissemination of OXA-48 in a veterinary clinical setting (Stolle
et al., 2013). Here, five OXA-48-producing K. pneumoniae (ST15)
and three E. coli (ST1196 and ST1431) recovered from six
diseased dogs, admitted to the UVC in 2012, were described.
The present study extends these data considerably with respect
to the investigation period (2009–2016), number of strains, and
involved veterinary clinics, providing insight into the chronology
and clonal diversity of OXA-48 strains. The earliest OXA-48
producer was a ST15-CTX-M-15 K. pneumoniae strain isolated
from a dog in the UVC in 2009. Nearly one year later, OXA-
48-producing E. cloacae strains (ST506) appeared in the same
clinic before we could identify an E. coli isolate (ST1196-SHV-
12) carrying an OXA-48 gene for the first time in the year
2012. The second dominant K. pneumoniae clone (ST11-DHA-1)
appeared nearly two years after the detection of the ST15 clonal
group. Thus, K. pneumoniae ST15 seems to represent the starting
point for the spread of OXA-48 in the UVC, although with the
limitation that data from earlier strains were not available. In
human medicine, epidemic clones of OXA-48-K. pneumoniae
are often initially recovered prior to other OXA-48-producing
Enterobacteriaceae isolates, and the horizontal transfer of OXA-
48 plasmids from K. pneumoniae to E. coli within the gut
of patients has been demonstrated (Goettig et al., 2015; Mairi
et al., 2017). Also consistent with what is known for humans,
K. pneumoniae was the most frequent OXA-48 producer in our
sample material, probably reflecting the ability of this species to
adapt to the hospital and veterinary clinical environment (Pitout
et al., 2015; Anonymous, 2016). The sudden drop of ST11- and
ST15-K. pneumoniae in the UVC in the second half-year of 2014
may be due to the implementation of improved cleaning and
disinfection measures along with an increased hygiene control
(personal communication).
The epidemic ST15-CTX-M-15 K. pneumoniae clone has
recently been reported in the context of veterinary clinic-acquired
infections in cats and dogs in France and Germany (Haenni
et al., 2012; Ewers et al., 2014b), while ST11-K. pneumoniae
carrying ESBL or AmpC β-lactamase genes were identified in
companion animals in Spain and Italy (Hidalgo et al., 2013;
Donati et al., 2014). Interestingly, ST11 and ST15 are also
dominant among human OXA-48-producing K. pneumoniae
isolates. Here, ST15 represents a globally disseminated clone
carrying ESBL and carbapenemases, particularly in Europe
and also in Germany (Kaase et al., 2016; Mairi et al., 2017).
ST11 has been involved in outbreaks in Spain and Tunisia
and is now found throughout Europe and other parts of
the world (Mairi et al., 2017). Consistent with the frequent
carriage of CTX-M-15 in human ST15 strains, >80% of the
animal OXA-48-ST15 isolates co-produced this ESBL enzyme,
whereas ST11 strains regularly co-expressed AmpC β-lactamase
DHA-1. Apart from ST15 and ST11, ST307 isolated from a
nasal and a wound swab from two dogs admitted to the
UVC was recently identified in the feces of six patients
in a hospital in Morocco. Like our strains, the human
ST307 K. pneumoniae co-expressed the CTX-M-15 ESBL, again
revealing similarities between human and animal strains (Girlich
et al., 2014).
Consistent with previous reports from humans, animal E. coli
isolates with OXA-48 were mostly polyclonal, with 11 different
STs identified among 22 strains. Nevertheless, the repeated
isolation of ST1196 from six animals in the UVC between March
and October 2012 also suggested clonal dissemination. Identical
plasmid patterns and co-expression of SHV-12 and CMY-2 was
observed in all but one of the ST1196 strains, further supporting
the clonal nature of the strains. This clone was also isolated from
a dog (dog-49) in external clinic-2 about 2 weeks after a ST15-
K. pneumoniae had been isolated from the same dog while he
had stayed in the UVC due surgical treatment of a portosystemic
shunt. This suggests an in vivo transfer of the OXA-48 plasmid
between different bacterial species, like previously shown for
humans and demonstrated for other animals in the present study
(Goettig et al., 2015). In dog-42, three different OXA-48 strains,
namely ST15-K. pneumoniae, ST1196-E. coli, and ST345-E. coli
were isolated from a wound. Dog-95 carried an ST744-E. coli and
an ST307-K. pneumoniae in one sample from the respiratory tract
taken five days after hospitalization in the UVC due to severe
aspergillosis. Both STs occurred for the first time in the UVC,
suggesting an introduction of this strain and the OXA-48 plasmid
by dog-95 or a transfer of the OXA-48 plasmid from one of the
dominant clones circulating in the clinic to newly entered strains.
Among the OXA-48 producing E. coli we could identify STs
which have previously been isolated from humans in different
geographic areas (Mairi et al., 2017). A clonal distribution
of ST648 occurred in Spain, the United Kingdom, and the
United States; ST58 and ST410 were recorded in Spain, and
ST1431 exhibited a clonal spread in Spain and Israel. Regarding
ST1196, strains carrying the VIM-1 carbapenemase have recently
been reported from human patients in Germany, while we are
not aware about the emergence of OXA-48 in this sequence
type (Kaase et al., 2015). ST410 was recently referred to as a
successful clone involved in the spread of ESBL genes, and genetic
similarities were identified between human and animal strains
(Poirel et al., 2014). Similarly, ST648 is reported increasingly as
an emerging resistance-associated genotype with extraintestinal
virulence potential in humans and animals and its zoonotic
potential has been indicated in previous studies (Pitout, 2012;
Ewers et al., 2014a). Besides from our findings, ST648 was one
of the six sequence types Liu et al. (2016) previously observed
among 13 OXA-48 producing E. coli from diseased dogs in the
United States. Another overlap in E. coli STs was revealed only
recently, as Melo et al. (2017) identified an OXA-48-producing
ST372 in a French dog, representing the first CPE in animals in
that country .
E. cloacae is an opportunistic pathogen frequently involved
in nosocomial infections and a number of studies have
demonstrated the emergence of OXA-48-producing strains in
hospitals worldwide (Poirel et al., 2012a; Potron et al., 2013;
Fernandez et al., 2015; Findlay et al., 2017). It has been
sporadically reported for companion animals as well (Schmiedel
et al., 2014; Yousfi et al., 2017). MLST distinguished seven
different STs among our 28 isolates with ST506 (39.3%), ST78
(21.4%), and ST114 together with its SLV ST418 (17.9%) being
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the predominant genotypes. Of note, ST114 and ST78 were
among the major lineages described for MDR E. cloacae and
have been identified as potential high-risk international clones
in Europe (Girlich et al., 2015; Izdebski et al., 2015). Also
other STs identified in the present study have been involved in
the clonal transmission of MDR isolates, such as ST124 in a
Chinese Tertiary Hospital (Cao et al., 2017). In contrast, ST506
represented a novel type, which was completely unrelated to
known STs. This clone repeatedly occurred in the UVC and
the IVP, located on the same campus, while it was not found
in any external clinic. Notably, six ST506 strains isolated in
different years, i.e., 2010, 2012, and 2014 revealed highly similar
PFGE types and all possessed SHV-12 and TEM-1, indicating
maintenance of the strains in the UVC for several years or
repeated entry. Only recently, Yousfi et al. (2017) suggested that
clonally related OXA-48-ST527-E. cloacae strains might have
circulated among healthy dogs at different dates and geographical
areas in Algeria. In our study, six ST78 isolates were distributed
among four clinics (UVC, clinic-3, clinic-6, and clinic-10), and
repeated isolation was only shown for clinic-3. This is consistent
with findings from humans, where this major E. cloacae ST
exhibits sporadic and clonal distribution (Fernandez et al., 2015;
Izdebski et al., 2015, 2017).
Our data show for the first time that the clonal distribution of
different genotypes, such as ST11- and ST15-K. pneumoniae,
ST1196-E. coli, and ST506-E. cloacae, may significantly
contribute to the spread of OXA-48 in companion animals. On
the other hand, the identification of several additional sequence
types and/or different Enterobacteriaceae species confirms
previous reports about the high transfer efficiency of a broad host
range 62-kb IncL plasmid harboring the blaOXA-48 genes located
within a composite transposon, namely Tn1999 (Poirel et al.,
2012b; Mairi et al., 2017). Insertion of Tn1999 into the tir gene,
encoding a transfer inhibition protein, was involved in the higher
transfer frequency of the plasmid pOXA-48a (Potron et al., 2014).
In our strain collection, blaOXA-48 was always located on a∼60-kb
plasmid. Sequencing of nine isolates revealed a highly conserved
blaOXA-48-carrying plasmid, which was almost identical to the
archetypal pOXA-48a, that contained Tn1999.2 (Poirel et al.,
2012b). This very much resembles the situation in humans, where
the emergence of OXA-48 among Enterobacteriaceae is mainly
related to the spread of one single plasmid.
CONCLUSION
We report the emergence of OXA-48 producing
Enterobacteriaceae in companion animals and pets, which is
related to the clonal spread of a few STs and the horizontal
dissemination of a single pOXA-48a-like plasmid. We have
indications for transmission of CPE isolates within at least
two veterinary clinics and suggest that such strains and/or the
OXA-48 plasmid can also be transferred between clinics by
animal carriers. Most importantly, significant overlaps between
human and animal strains could be revealed in terms of bacterial
sequence types and the OXA-48 plasmid. Since reports about
OXA-48-producing Enterobacteriaceae in animals appeared
several years after initial findings of these bacteria in humans
in the study area, there might be a spillover of OXA-48 plasmids
and/or OXA-48 producing Enterobacteriaceae from humans to
companion animals. However, further phylodynamic studies
based on whole genome sequencing would be necessary to
verify this hypothesis and to understand possible transmission
pathways more properly A systematic monitoring is urgently
needed to assess the dissemination of CPE not only in livestock
but particularly in companion animals and veterinary clinics on
a global scale.
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